Fig. 2From: Utility of in vitro release testing (IVRT) to assess ‘sameness’ of 1% clotrimazole creams for use as a biowaiverRelease rate profiles from SA-marketed 1% CLZ generic creams (SAn) and Canesten.® 1% CLZ (R1) (n = 6)Back to article page